ASRT

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Assertio Therapeutics Inc

NASDAQ | ASRT

0.79

USD

$0.00

(

0.00%

)

At Close (As of Nov 14, 2025)

$79.49M

Market Cap

-

P/E Ratio

-0.29

EPS

$1.08

52 Week High

$0.51

52 Week Low

HEALTHCARE

Sector

ASRT Chart

Recent Chart
Price Action

ASRT Technicals

Tags:

ASRT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $86M
Total Revenue $125M
Cost Of Revenue $39M
Costof Goods And Services Sold $39M
Operating Income -$24M
Selling General And Administrative $75M
Research And Development $3.8M
Operating Expenses $110M
Investment Income Net -
Net Interest Income $182K
Interest Income $3.2M
Interest Expense $3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $26M
Income Before Tax -$22M
Income Tax Expense $52K
Interest And Debt Expense -
Net Income From Continuing Operations -$22M
Comprehensive Income Net Of Tax -
Ebit -$21M
Ebitda $5.1M
Net Income -$22M

Revenue & Profitability

Earnings Performance

ASRT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $285M
Total Current Assets $203M
Cash And Cash Equivalents At Carrying Value $51M
Cash And Short Term Investments $51M
Inventory $38M
Current Net Receivables $54M
Total Non Current Assets $82M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $80M
Intangible Assets Excluding Goodwill $80M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $49M
Other Current Assets $10M
Other Non Current Assets -
Total Liabilities $164M
Total Current Liabilities $115M
Current Accounts Payable $15M
Deferred Revenue -
Current Debt -
Short Term Debt $331K
Total Non Current Liabilities $49M
Capital Lease Obligations $1.1M
Long Term Debt $39M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $40M
Other Current Liabilities $100M
Other Non Current Liabilities $5.5M
Total Shareholder Equity $121M
Treasury Stock -
Retained Earnings -$673M
Common Stock $9K
Common Stock Shares Outstanding $95M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $26M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $26M
Capital Expenditures $0
Change In Receivables -
Change In Inventory -$9.6M
Profit Loss -
Cashflow From Investment -$49M
Cashflow From Financing -$350K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$350K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$22M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $86M
Total Revenue $125M
Cost Of Revenue $39M
Costof Goods And Services Sold $39M
Operating Income -$24M
Selling General And Administrative $75M
Research And Development $3.8M
Operating Expenses $110M
Investment Income Net -
Net Interest Income $182K
Interest Income $3.2M
Interest Expense $3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $26M
Income Before Tax -$22M
Income Tax Expense $52K
Interest And Debt Expense -
Net Income From Continuing Operations -$22M
Comprehensive Income Net Of Tax -
Ebit -$21M
Ebitda $5.1M
Net Income -$22M

ASRT News

ASRT Profile

Assertio Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC

Assertio Therapeutics Inc. is a commercial pharmaceutical company headquartered in Lake Forest, Illinois, dedicated to developing and marketing innovative treatments with a focus on neurology, hospital-based therapies, and pain management. The company offers a diversified portfolio of pharmaceutical products aimed at addressing critical health challenges, underscoring its commitment to improving patient outcomes. Assertio's strategic emphasis on targeted therapeutic areas, combined with its robust distribution network and strategic partnerships, positions it well for growth and market expansion in the evolving healthcare landscape.

WTO
+19.50%
$0.02
LPTX
+368.57%
$2.05
ASBP
+1.04%
$0.10
AMZE
+1.80%
$0.40
VINE
+1.80%
$0.40
EPWK
+16.62%
$0.04
VHAI
+33.33%
$0.00
NVDA
+1.77%
$190.17
ONDS
+9.45%
$7.18
IVVD
+32.76%
$2.35
BYND
+6.93%
$1.08
ASST
-6.08%
$1.08
CHR
+1.67%
$0.04
TSLA
+0.58%
$404.35
PFE
-2.83%
$25.06
SOFI
-2.00%
$27.82
PLUG
-9.83%
$2.24
BITF
-0.76%
$2.58
NVVE
-45.37%
$0.25
ACHR
-1.00%
$7.88
ETHD
+1.75%
$5.23
INTC
-1.08%
$35.52
RGTI
+1.11%
$25.48
F
-0.67%
$13.19
AXDX
-61.36%
$0.03
PLTR
+1.08%
$174.01
RIVN
-7.80%
$15.11
TLRY
-4.42%
$1.08
CIFR
-3.81%
$14.36
SNAP
-0.11%
$8.57
WULF
-5.90%
$10.99
NIO
-1.28%
$6.16
WBD
+4.01%
$23.03
CRWV
-1.25%
$77.36
QBTS
+0.94%
$23.61
IONZ
-8.28%
$5.20
ADAP
-15.14%
$0.05
DNN
-0.40%
$2.48
BMNR
-5.93%
$34.40
DVLT
+18.83%
$1.83
IREN
-4.68%
$46.37
MARA
-6.18%
$11.99
AMD
-0.46%
$246.81
AAPL
-0.19%
$272.41
DFLI
+4.85%
$0.81
MKDW
-18.20%
$0.16
APLD
+2.55%
$23.65
APLT
-19.14%
$0.21
CLSK
-8.51%
$10.96
GRAB
-2.34%
$5.41
CAN
-8.04%
$0.89
RMBL
+60.50%
$3.21
AMZN
-1.21%
$234.69
LNW
-3.71%
$86.22
CSCO
+0.80%
$78.00
ADD
-25.47%
$0.05
QUBT
+5.68%
$10.60
CRCL
-0.54%
$81.89
T
-0.62%
$25.59
SMCI
+3.79%
$36.42
MU
+4.16%
$246.83
ORCL
+2.42%
$222.85
BTG
0.00%
$4.10
SRM
+53.27%
$10.30
KVUE
-0.65%
$16.66
BABA
-3.77%
$153.80
AAL
-2.37%
$12.76
BBD
+0.54%
$3.68
BAC
-0.49%
$52.61
HOOD
+0.79%
$122.50
NBIS
-5.74%
$83.54
GPUS
-7.60%
$0.27
RIOT
+0.50%
$13.95
GOOGL
-0.77%
$276.41
HIMS
+2.57%
$36.98
RXRX
-4.38%
$4.14
NOK
-0.73%
$6.73
JD
-4.55%
$29.31
PLTZ
-2.27%
$6.88
PLTD
-1.01%
$6.84
HPE
-0.43%
$22.83
QS
-1.03%
$13.43
BTBT
-4.36%
$2.41
IONQ
+3.92%
$47.18
VZ
-0.12%
$41.06
RIG
0.00%
$4.01
WLGS
-5.57%
$0.04
MSFT
+1.36%
$510.18
SOUN
-0.40%
$12.17
MTSR
-0.35%
$70.50
XPON
-8.66%
$1.16
XPEV
-5.19%
$25.01
BURU
-2.77%
$0.24
ABEV
+1.19%
$2.55
BTE
+0.63%
$3.16
SMR
-3.02%
$22.45
RGTZ
-2.55%
$27.42
DEFT
-15.17%
$1.23
VALE
-0.64%
$12.30
EOSE
-9.24%
$13.80
WTO
+19.50%
$0.02
LPTX
+368.57%
$2.05
ASBP
+1.04%
$0.10
AMZE
+1.80%
$0.40
VINE
+1.80%
$0.40
EPWK
+16.62%
$0.04
VHAI
+33.33%
$0.00
NVDA
+1.77%
$190.17
ONDS
+9.45%
$7.18
IVVD
+32.76%
$2.35
BYND
+6.93%
$1.08
ASST
-6.08%
$1.08
CHR
+1.67%
$0.04
TSLA
+0.58%
$404.35
PFE
-2.83%
$25.06
SOFI
-2.00%
$27.82
PLUG
-9.83%
$2.24
BITF
-0.76%
$2.58
NVVE
-45.37%
$0.25
ACHR
-1.00%
$7.88
ETHD
+1.75%
$5.23
INTC
-1.08%
$35.52
RGTI
+1.11%
$25.48
F
-0.67%
$13.19
AXDX
-61.36%
$0.03
PLTR
+1.08%
$174.01
RIVN
-7.80%
$15.11
TLRY
-4.42%
$1.08
CIFR
-3.81%
$14.36
SNAP
-0.11%
$8.57
WULF
-5.90%
$10.99
NIO
-1.28%
$6.16
WBD
+4.01%
$23.03
CRWV
-1.25%
$77.36
QBTS
+0.94%
$23.61
IONZ
-8.28%
$5.20
ADAP
-15.14%
$0.05
DNN
-0.40%
$2.48
BMNR
-5.93%
$34.40
DVLT
+18.83%
$1.83
IREN
-4.68%
$46.37
MARA
-6.18%
$11.99
AMD
-0.46%
$246.81
AAPL
-0.19%
$272.41
DFLI
+4.85%
$0.81
MKDW
-18.20%
$0.16
APLD
+2.55%
$23.65
APLT
-19.14%
$0.21
CLSK
-8.51%
$10.96
GRAB
-2.34%
$5.41
CAN
-8.04%
$0.89
RMBL
+60.50%
$3.21
AMZN
-1.21%
$234.69
LNW
-3.71%
$86.22
CSCO
+0.80%
$78.00
ADD
-25.47%
$0.05
QUBT
+5.68%
$10.60
CRCL
-0.54%
$81.89
T
-0.62%
$25.59
SMCI
+3.79%
$36.42
MU
+4.16%
$246.83
ORCL
+2.42%
$222.85
BTG
0.00%
$4.10
SRM
+53.27%
$10.30
KVUE
-0.65%
$16.66
BABA
-3.77%
$153.80
AAL
-2.37%
$12.76
BBD
+0.54%
$3.68
BAC
-0.49%
$52.61
HOOD
+0.79%
$122.50
NBIS
-5.74%
$83.54
GPUS
-7.60%
$0.27
RIOT
+0.50%
$13.95
GOOGL
-0.77%
$276.41
HIMS
+2.57%
$36.98
RXRX
-4.38%
$4.14
NOK
-0.73%
$6.73
JD
-4.55%
$29.31
PLTZ
-2.27%
$6.88
PLTD
-1.01%
$6.84
HPE
-0.43%
$22.83
QS
-1.03%
$13.43
BTBT
-4.36%
$2.41
IONQ
+3.92%
$47.18
VZ
-0.12%
$41.06
RIG
0.00%
$4.01
WLGS
-5.57%
$0.04
MSFT
+1.36%
$510.18
SOUN
-0.40%
$12.17
MTSR
-0.35%
$70.50
XPON
-8.66%
$1.16
XPEV
-5.19%
$25.01
BURU
-2.77%
$0.24
ABEV
+1.19%
$2.55
BTE
+0.63%
$3.16
SMR
-3.02%
$22.45
RGTZ
-2.55%
$27.42
DEFT
-15.17%
$1.23
VALE
-0.64%
$12.30
EOSE
-9.24%
$13.80
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.